Protein Structure Determination
    3.
    发明申请
    Protein Structure Determination 审中-公开
    蛋白质结构测定

    公开(公告)号:US20070050152A1

    公开(公告)日:2007-03-01

    申请号:US11510422

    申请日:2006-08-24

    IPC分类号: G06F19/00

    摘要: A method is provided for acquiring X-ray diffraction images of a protein crystal, the method comprising providing an X-ray source and a micro-channel, wherein the micro-channel contains an oil, gas or immiscible liquid and at least one aqueous droplet comprising a crystal of a protein, recording an X-ray diffraction image of the crystal, repositioning the crystal with respect to the X-ray source, and repeating the last two steps immediately above at least once.

    摘要翻译: 提供了一种用于获取蛋白质晶体的X射线衍射图像的方法,所述方法包括提供X射线源和微通道,其中所述微通道包含油,气体或不混溶液体和至少一个水滴 包括蛋白质的晶体,记录晶体的X射线衍射图像,相对于X射线源重新定位晶体,并且至少重复上述两个步骤至少一次。

    Variants and chemically-modified variants of phenylalanine ammonia-lyase
    4.
    发明申请
    Variants and chemically-modified variants of phenylalanine ammonia-lyase 失效
    苯丙氨酸氨裂解酶的变体和化学修饰的变体

    公开(公告)号:US20070048855A1

    公开(公告)日:2007-03-01

    申请号:US11230374

    申请日:2005-09-19

    IPC分类号: C12N9/88 G06F19/00

    摘要: The present invention pertains to the use of the protein phenylalanine ammonia-lyase, as well as the biologically-active derivatives of the said protein for preventing or treating diseases associated with a phenylalanine imbalance in a human or animal body. More particularly, the present invention relates to the therapeutic use of the above-cited molecules for preventing or treating a phenylalanine imbalance in vivo. This invention also deals with therapeutic compositions comprising a pharmaceutically active amount of the above-described therapeutic molecules as well as with therapeutic methods using the said therapeutic compositions. Finally, the present invention relates to processes for selecting more therapeutically-effective variants of said protein as well as to the selected variants themselves.

    摘要翻译: 本发明涉及蛋白质苯丙氨酸氨裂解酶的用途,以及所述蛋白质的生物活性衍生物用于预防或治疗与人或动物体内苯丙氨酸不平衡有关的疾病。 更具体地说,本发明涉及上述分子用于预防或治疗体内苯丙氨酸失衡的治疗用途。 本发明还涉及包含药物活性量的上述治疗分子以及使用所述治疗组合物的治疗方法的治疗组合物。 最后,本发明涉及用于选择所述蛋白质的更多治疗上有效的变体以及所选择的变体本身的方法。